Dublin, Aug. 10, 2017 -- The "Pharma App Benchmarking 2017" report has been added to Research and Markets' offering.
Since the first report about the app publishing activities of leading Pharma companies was published in 2014, companies have intensified their activities in the digital health market. This report analyses the current status of the app publishing activities of the twelve leading Pharma companies globally. It also analyses newly established channels that Pharma use to partner with 3rd party companies, including accelerators/incubators, investment funds and direct partnerships.
The research provides a detailed perspective on the current status of digital health activities, on a market and company level. It compares the digital health activities that Pharma companies concentrate on, and how successful they are. The report also highlights how app publishing strategies have changed over the last three years.
Key Topics Covered:
1. Scope of the report
2. Management summary
3. The four channels used by Pharma to drive digital innovation with mHealth apps
4. The app publishing activities of top Pharma companies
5. Top 12 Pharma company app portfolio comparison
6. Top 12 Pharma company app profiles and digital health innovation activities
7. How can Pharma further evolve their digital health strategies?
8. Appendix
Companies Mentioned
- Abbott/Abbvie
- AstraZeneca
- Bayer Healthcare
- Bristol-Myers Squibb
- GlaxoSmithKline
- Johnson&Johnson
- Merck
- Merck, Sharpe and Dohme (MSD)
- Novartis
- Pfizer
- Roche
- Sanofi
For more information about this report visit https://www.researchandmarkets.com/research/c28hjv/pharma_app
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Pharmaceuticals


Hyundai Motor Lets Russia Plant Buyback Option Expire Amid Ongoing Ukraine War
CK Hutchison Unit Launches Arbitration Against Panama Over Port Concessions Ruling
Jensen Huang Urges Taiwan Suppliers to Boost AI Chip Production Amid Surging Demand
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Palantir Stock Jumps After Strong Q4 Earnings Beat and Upbeat 2026 Revenue Forecast
Google Cloud and Liberty Global Forge Strategic AI Partnership to Transform European Telecom Services
NRW Holdings Shares Surge After Securing Major Rio Tinto Contract and New Project Wins
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
SoftBank and Intel Partner to Develop Next-Generation Memory Chips for AI Data Centers
Using the Economic Calendar to Reduce Surprise Driven Losses in Forex
Qantas to Sell Jetstar Japan Stake as It Refocuses on Core Australian Operations
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Tesla Launches New Model Y Variant in the US Starting at $41,990
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Sam Altman Reaffirms OpenAI’s Long-Term Commitment to NVIDIA Amid Chip Report 



